Johanna Friedl-Naderer, Chief Commercial Officer: Dyne Therapeutics DYN Sell · Filed 25/03/13

Trade details

Type: Insider sale
Amount: $1,733.16
Shares · price: 143 sh · $12.12 a share
Held after: 96,057 sh
Stock: Dyne Therapeutics DYN
Person: Johanna Friedl-NadererChief Commercial Officer
Trade date: 25/03/13
Filed: 25/03/13
Days to filing: 0 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

Johanna Friedl-Naderer's recent trades

Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,658
145 sh
$2,658
Filed 06/17
Traded 06/16
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$4,186
228 sh
$4,186
Filed 05/14
Traded 05/13
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,205
148 sh
$2,205
Filed 03/06
Traded 03/05
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$2,984
144 sh
$2,984
Filed 25/12/05
Traded 25/12/05
Johanna Friedl-NadererChief Commercial Officer
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$11.9K
894 sh
$11.9K
Filed 25/09/08
Traded 25/09/04